chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Fungal Infection in Rectum and Scrotum area along with severe itching in these areas and itching all over my body, neck, stomach, legs, feet.
Epigastric pain, nausea, diarrhea, decreased appetite, unintended weight loss, extreme fatigue, low grade fevers, headaches, abdominal pain, gas/bloating, chest pain, redness/flushing of face and ears, joint pain, hand and foot swelling/redness/pain, increased thirst, intermittent hives, petechial rash, constant tinnitus, abnormal menstrual cycles, intermittent vulvar fissures, pain and redness of the tips of the toes, abnormal bruising, skin angiomas, night sweats, temperature dysregulation (feeling too hot or too cold), chills, clear nasal discharge (runny nose), difficulty concentrating, short term memory loss, ?brain fog?, blurred vision, sore gums, splenomegaly, hepatomegaly, increased liver enzymes, lymphocytosis, neutropenia, light headedness, soreness on forehead/scalp area, lower BPs, sweating, clumsy while walking
Can't get fully hard and can't complete. Got the flu cannot have fully ejaculation weak orgasm.
aching a few dasy disappeared x 1wk, now back w/pain to thumb, staring @ shoulder;
Caller stated a female patient was 26 years old when she received the first dose in May 2022. Per caller, the patient has not yet received the second dose. Caller had no further details. No permission to con; No adverse event; This spontaneous report was received from a pharmacist and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date in May 2022, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, administered for prophylaxis (strength, lot #, expiry date, and route of administration were not provided). Per caller, the patient has not yet received the second dose (inappropriate schedule of product administration ). No additional adverse event was reported.
body aches are awful; Initial information received on 18-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-hcp.  This case involves Adult and unknown gender patient who experienced body aches are awful while receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (strength, formulation, dose, expiration date and lot number not reported) via unknown route in unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious body aches are awful (pain) (unknown latency).  Lab data was not reported.  Action taken was not applicable.  Corrective treatment was not reported for the event (body aches are awful).  Outcome was Unknown for the event body aches are awful.
Heart rate nearly doubled normally 60 beats per min now 100 to 110 beats per min consistently with mild heart pain  No changes in activity or stress taken in June 2021 and these side effects happened as well and  took heart rate two months to go back down to normal
Fainted but responded when I  talked to her. Had her lie on floor. Gave cold compress and cold water to drink.  She stayed awake from then on. We sat her up and had her wait until she felt better. Waited here 30 minutes after vaccine and felt ok when she left.
S: Patient presents for ER f/u of immunization reaction concerns. Yesterday, she had an immz. only visit at facility and received her 1st dose of Gardasil HPV in right arm at 3:54 pm and 1st dose of Menveo Meningococcal ACYW in right arm at 3:55 pm. Mother reports she was in her usual state of health yesterday and felt fine that evening laughing and participating in family activities, then around 9 pm her eyes suddenly seemed puffy and she got a confused look on her face, saying she was dizzy. She additionally developed clamminess/chills without fever, nausea without vomiting and a headache which is throbbing over her whole head without vision or hearing changes. Mother called the after hours line and was directed to take patient to ER, where they waited for "hours" with patient evaluated by provider at 3:54 am (per record note) with limited w/u including rapid strep, which was negative, and impression that symptoms were likely due to vaccinations.  Mother reports that today, Patient is about the same with all symptoms above still present. Patient reports she has a stuffy nose and non-phlegmy cough, which mother has not noticed. She denies neck stiffness, difficulty swallowing, ear or throat pain, rashes or diarrhea. She adds that she feels achy btu can move all extremities without difficulty. Right arm is sore at injection site with no known swelling. Patient has a decreased appetite today though has tolerated water and fruit and has voided a couple of times. She took ibuprofen yesterday and tylenol today without much improvement. There is no prior history of immunizations or known drug allergies.  O: Patient ambulatory, conversational, laughing at times. Exam significant for mild eyelid swelling and mild pharyngeal inflammation. Additional systems examined (ears, nose, mouth, neck, skin, lungs, heart, abdomen, neurological) all WNL. A: Possible immunization reaction versus acute infection. P: Detailed discussion with mother regarding possible immunization reaction to either HPV or Menveo versus infection, given acute onset. Convoluted history from mother regarding possible meningitis last year with similar symptoms, with records requested to review more thoroughly, however advised mother that at this time, patient does not have any signs of meningitis and that meningitis immunization does not cause meningitis infection. Rapid flu negative and COVID test ordered; as patient overall well appearing today will defer additional w/u unless symptoms worsen or do not improve as expected over the next 5-7 days. Zofran prescribed for nausea with administration discussed, recommend offering Pediasure and OTC ibuprofen/Tylenol PRN discomfort. Go to ER if syncope, neck stiffness, no voids for 8 hours, changes in speech/coordination, severe worsening of headache or any other concerns. Mother verbalizes understanding. Will report presentation to VAERS.
No patients experienced any adverse effects; Improperly stored dose of ROTATEQ; This spontaneous report was received from a physician concerning a patient of unknown age and gender. No information was provided regarding the patient's pertinent medical history, concomitant medications, or drug reactions/allergies.     On 15-MAY-2020, the patient was vaccinated with an improperly stored dose of Rotavirus Vaccine, Live, Oral, Pentavalent (ROTATEQ) vial (product storage error), by oral route (lot # 1660693, has been verified to be a valid lot number; expiration date 19-MAR-2021) as prophylaxis (dosage schedule and strength were not reported).   The administered dose of the vaccine experienced a multiple temperature excursions below highest temperature above 47 Fahrenheit degrees  to 66.6 Fahrenheit degrees for 2 hours and lowest temperature below 36 Fahrenheit degrees to 33.6 Fahrenheit degrees  for 45 minutes as recorded by a data logger. There was no previous temperature excursion. There was no adverse effect reported.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2006USA001703:
Joint, muscle and bone pain for over 5 weeks now.  My feet and hands are suffering the most.
One week post vaccination, injection site became red, swollen and hot to touch. Developed body tremors, headaches, neck tightness,  severe pain and reduced range of motion. Twice weekly migraines.
Inflammation + flu like symptoms. Pain from top of head to toes. Upset stomach which lasted around 2 days.
Flu-like symptoms, aching, nasal congestion, fatigue, headache for four days. Developed hives on day 6 and 7 (elbows, knees) after injection.  No treatment sought.
Normal side effects of itching, fatigue, soreness and swelling. But also reported Dizziness and lightheadness.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. On or about 01-JUL-2008, the patient was inoculated with ZOSTAVAX at a clinic as recommended for routine adult health maintenance and for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster. On or about 01-OCT-2010, the patient was treated at the same clinic for a persistent and severe vesicular rash, which was diagnosed as herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown. Causality assessment was related. Additional information has been requested.
I began feeling my entire body inflame; Extreme Tachycardia; This spontaneous case was reported by a nurse and describes the occurrence of TACHYCARDIA (Extreme Tachycardia) and INFLAMMATION (I began feeling my entire body inflame) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037A21B.) for COVID-19 vaccination.     Concurrent medical conditions included Peanut allergy, Allergy to nuts and Soy allergy. Concomitant products included METOPROLOL, ROSUVASTATIN CALCIUM (CRESTOR), LORATADINE (CLARITIN [LORATADINE]), CALCIUM, VITAMINS NOS, LEVOTHYROXINE, EZETIMIBE (ZETIA) and RAMIPRIL for an unknown indication.    On 31-Mar-2021 at 6:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Mar-2021, the patient experienced TACHYCARDIA (Extreme Tachycardia). On an unknown date, the patient experienced INFLAMMATION (I began feeling my entire body inflame). The patient was treated with METOPROLOL TARTRATE (LOPRESSOR) for Hypertension, at an unspecified dose and frequency. At the time of the report, TACHYCARDIA (Extreme Tachycardia) was resolving and INFLAMMATION (I began feeling my entire body inflame) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 31-Mar-2021, Blood pressure measurement: 200/110 (High) recovering/resolving outcome. On 31-Mar-2021, Heart rate: 160 (High) pulse was 140 and climbing &  HR was above 160; unknown outcome.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The treatment information included intravenous (IV) fluid. She states that she will not take the 2nd dose of vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: significant follow up included, Height, weight, race and ethnicity. Patient concomitant included Levothyroxine 50 mcg QD. New events included Heart rate increase ( Labs), inflammation and blood pressure increased (Labs)
This spontaneous report as received from a healthcare workr refers to unspecified number of patients of unknown demographics. On unspecified dates, the patients were vaccinated with PROQUAD (merck) (dose, frequency unknown). No concomitant medication was reported. The healthcre worker reported patients received less than recommended dose of PROQUAD due to incorrect reconstitution methods. Healthcare worker reported that the full amount of diluent was being drawn up to reconstitute the product but then only 0.5 millilitre of reconstituted product was being administered to the patients. No adverse effects were reported. No product quality complaint was reported. The outcome of events was unknown. This case is related with 1407USA008555, 1407USA008557, 1407USA008558, 1407USA007501 and 1407USA008559 via same reporter link. Additional information has been requested.
Pain in left arm. Fever (102.7). Chills. Fatigue. Headache. Dizziness. Light-headedness. ... All lasting at least 15 hours. Cleared upby the next morning.
Injection site pain; Headache; Chills; Feeling unwell; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 07Apr2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, the patient experienced injection site pain, headache, chills, diarrhea and also the patient felt unwell. On 10Apr2021, post vaccination, the patient underwent nasal swab test and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events injection site pain, headache, chills, feeling unwell and diarrhea were resolving at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
PT RECEIVED 2ND DOSE OF SHINGRIX ON 5/20.  SAID BY THE NEXT DAY SHE FELT SWELLING & TENDERNESS IN THE LEFT ARMPIT & INTO THE LEFT BREAST.   BY 5/23, THE SWELLING & TENDERNESS WAS STILL PRESENT.  SHE CALLED THE PHARMACY TODAY TO REPORT IT.
This case was reported by a physician via call center representative and described the occurrence of allergic reaction in a patient who received FLUARIX QUADRIVALENT. On an unknown date, the patient received FLUARIX QUADRIVALENT at an unknown dose. On an unknown date, less than a year after receiving FLUARIX QUADRIVALENT, the patient experienced allergic reaction, wheals and skin red. On an unknown date, the outcome of the allergic reaction, wheals and skin red were unknown. It was unknown if the reporter considered the allergic reaction, wheals and skin red to be related to FLUARIX QUADRIVALENT. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced allergic reaction to dose of FLUARIX QUADRIVALENT confirmed by skin test as wheal intradermal flare type of reaction. The doctor of medicine (MD) did not want to give additional information about the adverse event until he was provided with some information.
patient admitted to local Hospital for back surgery 7/7/22, subsequently tested positive for covid 7/21/22 while recovering in rehab
Initial unsolicited report was received from a certified medical assistant on 23 February 2015. This case is one of a cluster of "almost 10 patients" (eight of which were identified) received from the same reporter. The other patients are captured in cases 2014SA157362, 2015SA023263, 2015SA023267, 2015SA023893, 2015SA023902, 2015SA023917, 2015SA023924 and 2015SA023928. A 63 year-old male patient had received on 14 October 2014 a left arm injection of FLUZONE (lot number UI197AC with expiration date of 30 June 2015) and 14 days later on 28 October 2014 was diagnosed with pneumonia and flu. Laboratory and diagnostic testing were unknown. Illness at the time of vaccination was reported as "non-healthy". Concomitant medications and pre-existing conditions were reported as "NA". No further information was provided. Outcome was recovered. According to the reporter, the report was reviewed and they had no additional information to report at the time. Documents held by sender: none.
SHARP PAINFUL TINGLES ALL OVER HEAD ITCHY TINGLES FACE/LIPS EYES SCRATCHY AND PAINFUL TINGLING SENSATION CONTINUED BILATERALLY UPPER EXTREMITIES , THEN SETTLING ON RIGHT SIDE ONLY THEN CONTINUED TO HIPS AND THIGHS CONTINUED TO FEET ONCE AT FEET, NUMBING SENSATION OCCURRED WITH RIGHT LOWER EXTREMITY AFFECTED MORE ACUTELY THAN LEFT RIGHT EXTREMITY CONTINUED WITH NUMBING/TINGLING SENSATION FROM FOOT TO KNEE, THEN SETTLED PRIMARILY OUTER SIDE OF RIGHT LEG  UPON WAKING IN MORNING, RIGHT LEG STILL AFFECTED BUT LESS ACUTELY.  WAVES OF TINGLING SENSATIONS THROUGHOUT 11/03/2009 SUBSIDED AROUND 3-4:00PM 11/03/2009
Patient stated had neuropathy fingertips, fever 102, neuropathy involved both hands lasted about 12 hours. Fever about 12 hours. Patient stated took 1000mg TYLENOL. Patient did not contact Health Dept. regarding symptoms until 10/17/12. Patient stated was feeling better patient not sure of time of onset of symptoms on 10/15/12.
The hospital gave my mom the Johnson shot on May 18,21.( I was not informed about it until my my told me on May 20th ) she said she had a headache and stomach, My mom was scheduled for an angiogram that day but they couldn't do it then because the doctor had an emergency. So they schedule it for Saturday but they couldn't do it because my mom had an upset stomach. They then schedule it for the 24th but they couldn't do it because her vitamin k and plasma level's were off. So they gave her vitamin k and plasma in the morning of the 25th and said they could do the angiogram. When she came back to the room her blood pressure was extremely low and she was very bloated. I was told they couldn't do the procedure because she had blood clots in her leg. And the bloating was due to fluids they gave her to flush out the heparin they gave her. Later that evening she passed away
Last night (4 hours after injection) axillary lymphnodes on injection side were enlarged and severely painful. Upon waking this morning axillary lymphnode pain persists, left inguinal lymphnode is painful, moderate to severe fatigue and temperature of 99.9 degrees when checked at work with mild dizziness. Heart palpitations while trying to sleep last night, resting heart rate was 86 BPM higher at times.
Information has been received from a registered nurse concerning a 6-month-old male who on 07-MAY-2008 was vaccinated orally with a first dose of ROTATEQ (lot # 659773/0020X).  No adverse effects reported.  The patient did not seek medical attention.  A product complaint was not involved.  Additional information has been requested.
Woke up at 7am 8/18/04 with swelling and redness in upper left arm. 4x4 cm area of induration. Fever up to 104 degrees on 8/18/04.
Child had brief tonic/clonic seizure. 1 hr after receiving vaccines. Returned to clinic with temp of 100.7 (unmedicated). Developed cold symptoms the following day.
Bruising at site of injection. Major pain and soreness for 10 days. Pain in arm and shoulder. Stiffness in arm. Patient in tears.
ErythemaMultiform 3 INCH INJECTION SITE REDNESS, HARD,  ITCHING, WARM. RESOLVED IN THREE DAYS. Narrative:
COVID-19 virus; Coughing; sore throat; nausea; headache; chills; Body aches; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID-19 virus), COUGH (Coughing), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea) and HEADACHE (headache) in a 22-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID-19 virus), COUGH (Coughing), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea), HEADACHE (headache), CHILLS (chills) and MYALGIA (Body aches). The patient was treated with GUAIFENESIN (MUCINEX) at an unspecified dose and frequency. At the time of the report, SARS-COV-2 TEST POSITIVE (COVID-19 virus), COUGH (Coughing), OROPHARYNGEAL PAIN (sore throat), NAUSEA (nausea), HEADACHE (headache), CHILLS (chills) and MYALGIA (Body aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided.
3 months after the shot, I was diagnosed with Hydrocephalus; Sleep Apnea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old male patient received BNT162b2 (BNT162B2), on 19Mar2021 at 17:15 as dose 2, single (Lot number: EN6208), in right arm for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Vaccination history included: BNT162b2 (prev dose product=COVID 19, prev dose brand= Pfizer, prev dose brand unknown= False, is bivalent=False, prev dose lot number=E N6200, prev dose lot unknown= False, prev dose administration date=26Feb2021, prev dose dose number= 1, prev dose vaccine location= Right arm), administration date: 26Feb2021, when the patient was 66-year-old, for COVID-19 immunization. The following information was reported: HYDROCEPHALUS (hospitalization, medically significant) with onset 01Jun2021, outcome "recovered", described as "3 months after the shot, I was diagnosed with Hydrocephalus"; SLEEP APNOEA SYNDROME (hospitalization, medically significant) with onset 01Jun2021, outcome "recovered", described as "Sleep Apnea". The patient was hospitalized for hydrocephalus, sleep apnoea syndrome (hospitalization duration: 1 day(s)). The events "3 months after the shot, i was diagnosed with hydrocephalus" and "sleep apnea" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (01Sep2022) Negative. Therapeutic measures were taken as a result of hydrocephalus, sleep apnoea syndrome. Patient did not receive any other vaccine in four weeks and did not receive other medication in two weeks. Patient did not have covid prior vaccination. 3 months after the shot, patient was diagnosed with Hydrocephalus and Sleep Apnea with no previous symptoms or history. Patient needed surgery for the Hydrocephalus. Hospitalized for one day. No known allergies. No other medical history.  Follow-up attempts are completed. No further information is expected.
Experienced low grade fever, headache, joint pain, chills, which progressed into rash all over face, front torso, back, and upper and lower extremities this then progressed into body aches and diarrhea.
HAVE HAD MIGRAINES SINCE I WAS A TEEN. MIGRAINES UNDER CONTROL WITH TYLENOL OR IBUPROFEN. AFTER SECOND DOSEOF PFIZER VAC MIGRAINES 5-7 DAYS WEEKLY WITH AURAS.   MIGRAINES UNMANAGEMANABLE WITH OVER THE COUNTER MEDICATIONS. HAD TO SEE NEUROLOGY THEN HAVE MRI. MIGRAINES WERE 5-7 DAYS A WEEK WITH AURAS. DUE SEVERITY AND TIMEFRAME DR HAS DETERMINED IN MY CASE I HAVE HAD A REACTION TO VACCINATION. I AM NOW ON MIGRAINE MEDICATION FOR BREAKTHROUGH 3RD MEDICATION FOR MIRGRAINES DOESNT NOT WORK. TAKING DAILY TOPAMAX WHICH SEEMS TO BE HELPING AT THIS TIME